Zobrazeno 1 - 10
of 53
pro vyhledávání: '"D. Belvini"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Paolo Radossi, Patrizia Pontisso, M. Gerotto, R. Salviato, G. Tagariello, D. Belvini, Alfredo Alberti
Publikováno v:
Haemophilia. 10:81-86
Summary. Patients with haemophilia show high prevalence of hepatitis C infection but low rate of progressive liver disease when they are not co-infected with HIV. The balance between host immune system and hepatitis C virus (HCV) variability seems to
Publikováno v:
Haemophilia. 8:17-21
Haemophilia A displays a broad heterogeneity of genetic defects and of clinical severity. Inhibitor development is the main complication of replacement therapy in severe cases and most patients with inhibitors have gross gene rearrangement or point m
Autor:
Antonio Girolami, Fabrizio Vianello, F. Dal Bello, Ezio Zanon, Giuseppe Tagariello, P. Zerbinati, D. Belvini, Anna M. Lombardi
Publikováno v:
Haemophilia. 7:511-514
Haemophilia B patients with factor IX (FIX) activity < 1% are usually characterized by severe bleeding episodes early in life. We report a case of sporadic severe haemophilia B, clinically characterized by mild bleeding diathesis. The presence of ana
Publikováno v:
Haemophilia. 10:194-196
Autor:
Ezio Zanon, Giancarlo Castaman, F. Pierobon, Giorgio Gandini, Paolo Radossi, Roberto Sartori, D. Zanotto, D. Belvini, R. Salviato, G. Tagariello
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 13(4)
Summary. Anti factor VIII (FVIII) antibodies represent the main complication of replacement therapy in severe cases of haemophilia and most patients with inhibitor have gross gene rearrangements or point mutations that hamper the production of normal
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 8(1)
Haemophilia A displays a broad heterogeneity of genetic defects and of clinical severity. Inhibitor development is the main complication of replacement therapy in severe cases and most patients with inhibitors have gross gene rearrangement or point m
Autor:
F, Vianello, D, Belvini, F, Dal Bello, G, Tagariello, E, Zanon, A M, Lombardi, P, Zerbinati, A, Girolami
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 7(5)
Haemophilia B patients with factor IX (FIX) activity1% are usually characterized by severe bleeding episodes early in life. We report a case of sporadic severe haemophilia B, clinically characterized by mild bleeding diathesis. The presence of anamne
Publikováno v:
Haemophilia. 7:603-604